ROCK
Los inhibidores de la quinasa asociada a Rho (ROCK) se dirigen a las quinasas ROCK, que están involucradas en la regulación del citoesqueleto, la forma celular y la motilidad. ROCK desempeña un papel significativo en el control de la división celular, particularmente en procesos como la citocinesis. Inhibir ROCK puede provocar cambios en la dinámica del ciclo celular, la motilidad celular y la apoptosis, lo que hace que estos inhibidores sean valiosos en la investigación del cáncer, la neurobiología y los estudios cardiovasculares. En CymitQuimica, ofrecemos una selección de inhibidores de ROCK de alta calidad para apoyar su investigación en biología celular, dinámica del citoesqueleto y mecanismos de enfermedades.
Se han encontrado 67 productos de "ROCK"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Rho-Kinase-IN-1
CAS:Rho-Kinase-IN-1: ROCK inhibitor, Ki of 30.5 nM (ROCK1) & 3.9 nM (ROCK2), used in research for diseases linked to cell overgrowth and inflammation.Fórmula:C20H24N4SPureza:99.8%Forma y color:SolidPeso molecular:352.5CRT0066854 hydrochloride
CAS:CRT0066854 HCl inhibits atypical PKCs; IC50: PKCι 132 nM, PKCζ 639 nM, ROCK-II 620 nM.Fórmula:C24H27Cl2N5SPureza:99.63%Forma y color:SolidPeso molecular:488.48ROCK-IN-7
CAS:ROCK-IN-7 (compound 9) serves as a ROCK kinase inhibitor and is utilized in the investigation of ocular conditions, including glaucoma and retinal diseases [1].Fórmula:C17H17N3O2SPureza:98%Forma y color:SolidPeso molecular:327.4Chroman 1
CAS:Chroman 1 is a potent inhibitor of ROCK1 (IC50 = 52 pM) and ROCK2 (IC50 = 1 pM).Fórmula:C24H28N4O4Pureza:99.67% - 99.84%Forma y color:SolidPeso molecular:436.5ROCK-IN-9
CAS:<p>ROCK-IN-9 (Compound T345), a ROCK inhibitor, exhibits cytotoxicity in HepG2 cells with an IC50 of 40.8 μM.</p>Fórmula:C20H20FN5O2Pureza:98%Forma y color:SolidPeso molecular:381.4ROCK2-IN-6 hydrochloride
CAS:ROCK2-IN-6 hydrochloride (Comp A)为一种选择性ROCK2抑制剂，适用于研究ROCK介导的疾病、自身免疫性病症与炎症。Fórmula:C26H22ClF2N7OPureza:98%Forma y color:SolidPeso molecular:521.95ROCK-IN-8
CAS:ROCK-IN-8 (Example 4), a ROCK inhibitor, exhibits anti-inflammatory properties and is suitable for respiratory and gastro-intestinal disease research,Fórmula:C30H25FN4O4SPureza:98%Forma y color:SolidPeso molecular:556.61ROCK2-IN-2
CAS:ROCK2-IN-2 is a selective inhibitor of ROCK2 (IC50 of <1 μM).Fórmula:C18H12N6OSPureza:99.65%Forma y color:SolidPeso molecular:360.39LX7101
CAS:LX7101 is an effective inhibitor of LIMK and ROCK2 (IC50: 24, 1.6, and 10 nM for LIMK1, LIMK2, and ROCK2, respectively). It also inhibits PKA (IC50 <1 nM).Fórmula:C23H29N7O3Pureza:99.08%Forma y color:SolidPeso molecular:451.52ROCK-IN-1
CAS:<p>ROCK-IN-1 is a potent ROCK inhibitor that inhibits ROCK2-mediated signaling with an IC50 value of 1.2 nM.ROCK-IN-1 can be used in the study of neurological</p>Fórmula:C20H18FN3OPureza:>99.99%Forma y color:SolidPeso molecular:335.37H-1152 dihydrochloride
CAS:H-1152 2HCl: ROCK inhibitor, IC50=12 nM, Ki=1.6 nM. Blocks PKA, PKC, PKG, Aurora A, CaMKII with higher IC50s.Fórmula:C16H23Cl2N3O2SPureza:99.85%Forma y color:SolidPeso molecular:392.34ROCK-IN-11
CAS:ROCK-IN-11 (example 94) is an effective inhibitor of ROCK1 and ROCK2, with an IC50 of ≤ 5 μM, and plays a significant role in cancer research.Fórmula:C22H20N4O4SForma y color:SolidPeso molecular:436.484ROCK/HDAC-IN-1
<p>ROCK/HDAC-IN-1 (Compound 10h) serves as an orally effective inhibitor of ROCK/HDAC. This compound suppresses ROCK1/2 (IC50: 254.9 nM, 58.18 nM) and HDAC1/2/3/6/8 (IC50: 9.09, 8.03, 6.26, 0.41, 7.69 nM). It stimulates the activation of DAMPs, notably calreticulin (CRT) exposure and HMGB1 release, suggesting its potential as an inducer of immunogenic cell death (ICD). ROCK/HDAC-IN-1 exhibits antiproliferative effects against breast cancer cells (IC50: 0.37 μM for MDA-MB-231 cells), inhibits tumor growth, activates T cells, and shows no significant toxicity.</p>Fórmula:C19H22N4O3SForma y color:SolidPeso molecular:386.47Rhodblock 1a
CAS:<p>Rhodblock 1a is an inhibitor of the Rho kinase signaling pathway, which disrupts the localization and function of proteins within the Rho pathway. This interference hinders the proper formation of the cleavage furrow during cell division, leading to some cells either failing to form the cleavage furrow or forming a ruptured furrow, resulting in binucleated cells. Rhodblock 1a can be utilized for investigating cell division mechanisms and holds potential for research into cardiovascular diseases and cancer.</p>Fórmula:C20H16N2O2Forma y color:SolidPeso molecular:316.353Zelasudil
CAS:<p>Zelasudil (RXC007) is a Rho-related (ROCK) kinase inhibitor for the study of idiopathic pulmonary fibrosis and inflammation.</p>Fórmula:C22H21F2N7OPureza:99.15%Forma y color:SolidPeso molecular:437.445ROCK2-IN-6
CAS:<p>ROCK2-IN-6 (Comp A) is a selective inhibitor of ROCK2, applicable in the study and treatment of ROCK-mediated, autoimmune, and inflammatory diseases [1].</p>Fórmula:C26H21F2N7OPureza:98%Forma y color:SolidPeso molecular:485.49ROCK-IN-6
CAS:<p>ROCK-IN-6, a selective ROCK2 inhibitor, exhibits potent inhibition with an IC50 of 2.19 nM and holds promise for research into glaucoma and retinal diseases [1</p>Fórmula:C19H19N5O8SPureza:98%Forma y color:SolidPeso molecular:477.45Ref: TM-T79077
Producto descatalogado
